Autolus Therapeutics plc (NASDAQ:AUTL – Get Rating) saw an uptick in trading volume on Wednesday . 1,574,079 shares traded hands during trading, an increase of 172% from the previous session’s volume of 577,823 shares.The stock last traded at $2.93 and had previously closed at $2.47. Analyst Upgrades and Downgrades Several research firms recently issued reports […]
Autolus Therapeutics plc (NASDAQ:AUTL – Get Rating) was the target of a significant drop in short interest in the month of April. As of April 30th, there was short interest totalling 861,000 shares, a drop of 33.3% from the April 15th total of 1,290,000 shares. Based on an average daily trading volume, of 530,500 shares, […]
Autolus Therapeutics (NASDAQ:AUTL – Get Rating) had its price target decreased by Wells Fargo & Company from $8.00 to $6.00 in a research report released on Friday, The Fly reports. Several other equities analysts also recently issued reports on AUTL. Needham & Company LLC reissued a buy rating and set a $7.00 price target on […]
Autolus Therapeutics (NASDAQ:AUTL – Get Rating) had its price objective reduced by Wells Fargo & Company from $8.00 to $6.00 in a research note issued to investors on Friday morning, The Fly reports. A number of other brokerages also recently commented on AUTL. Bryan, Garnier & Co started coverage on shares of Autolus Therapeutics in […]